Related Experiment Videos
[Right ventricular function assessed by scintigraphy using continuous infusion of krypton-81 m]
Summary
Krypton-81m (81mKr) scintigraphy accurately measures right ventricular ejection fraction (RVEF). This noninvasive method shows strong correlation with technetium-99m techniques and cardiac CT, validating its use in assessing RVEF.
Area of Science:
- Nuclear Medicine
- Cardiology
- Radiology
Background:
- Right ventricular ejection fraction (RVEF) is a critical indicator of cardiac health.
- Accurate, noninvasive methods for RVEF assessment are essential in clinical practice.
Purpose of the Study:
- To evaluate the accuracy and reproducibility of krypton-81m (81mKr) scintigraphy for determining RVEF.
- To compare 81mKr scintigraphy with established imaging modalities and hemodynamic measurements.
Main Methods:
- Continuous infusion 81mKr scintigraphy was used to measure RVEF in patients.
- RVEF values were compared with those obtained from technetium-99m (99mTc) first-pass technique and multislice ECG-gated cardiac CT.
- Correlation with hemodynamic parameters and other determinants of right ventricular function was assessed.
Main Results:
- 81mKr scintigraphy demonstrated good correlation with the 99mTc first-pass technique (r = 0.86) and cardiac CT (r = 0.76).
- A significant inverse correlation was found between RVEF and pulmonary artery pressure/total pulmonary resistance.
- Right coronary artery disease, reduced left ventricular function, and tricuspid regurgitation were identified as other determinants of RVEF.
Conclusions:
- Continuous infusion 81mKr scintigraphy is a reliable and noninvasive method for RVEF determination.
- The technique shows excellent agreement with other imaging modalities, supporting its clinical utility.
- 81mKr scintigraphy aids in understanding the complex factors influencing right ventricular systolic function.